¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"fermentation factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
plasma thromboplastin factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ
platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
platelet factor 3
Ç÷¼ÒÆÇÀÎÀÚ3
platelet factor 4
Ç÷¼ÒÆÇÀÎÀÚ4
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ħÀüÀÎÀÚ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
prolactin inhibitory factor
ÇÁ·Î¶ôƾºÐºñ¾ïÁ¦ÀÎÀÚ
prolactin releasing factor
ÇÁ·Î¶ôƾºÐºñÀÎÀÚ
properdin factor B
ÇÁ·ÎÆä¸£µòBÀÎÀÚ
properdin factor D
ÇÁ·ÎÆä¸£µòDÀÎÀÚ
properdin factor E
ÇÁ·ÎÆä¸£µòEÀÎÀÚ
protein synthesis factor
´Ü¹éÇÕ¼ºÀÎÀÚ
psychogenic factor
Á¤½Å¼ºÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
psychosocial factor
½É¸®»çȸÀû¿äÀÎ
quality factor
Áú¿ä¼Ò, Á¤¼ºÀÎÀÚ
racial factor
ÀÎÁ¾¿äÀÎ
radiation weighting factor
¹æ»ç¼±°¡Áß°è¼ö
realization factor
½ÇÇöÀÎÀÚ
recruitment factor
µ¿¿øÀÎÀÚ
reducing factor
ȯ¿øÀÎÀÚ
reinforcing factor
°È¿äÀÎ
relaxing factor
ÀÌ¿ÏÀÎÀÚ
resistance factor
³»¼ºÀÎÀÚ, °ßµõÀÎÀÚ
resistancetransfer factor
³»¼ºÀü´ÞÀÎÀÚ
reticuloendothelial depressant factor
¼¼¸Á³»Çǰè¾ïÁ¦ÀÎÀÚ, ±×¹°³»Çǰè¾ïÁ¦ÀÎÀÚ
rheumatoid factor
·ù¸¶Æ¼½ºÀ¯»çÀÎÀÚ
risk factor
À§ÇèÀÎÀÚ
roentgen-to-rad conversion factor
·ÛÆ®°Õ¶óµåº¯È¯°è¼ö
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
hypothalamus releasing factor
½Ã»óÇϺÎÀ¯¸®ÀÎÀÚ.
inhibition(-tory) factor, macrophage migration
´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ
intensity factor
°µµÀÎÀÚ
plasma coagulation factor
Ç÷ÀåÀÀ°íÀÎÀÚ
plasma factor
Ç÷ÀåÀÎÀÚ(úìíìì×í), ÇöóÁÀÎÀÚ.
plasma factor
Ç÷ÀåÀÎÀÚ(úìíìì×í), ÇöóÁÀÎÀÚ(¡ì×í)
plasma thromboplastic factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ.
plasma thromboplastin factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ.
platelet activating factor
Ç÷¼ÒÆÇ Ȱ¼º ÀÎÀÚ
platelet factor 4
Ç÷¼ÒÆÇÀÎÀÚ(úìá³÷ùì×í) 4
platelet factor 4=PF4
Ç÷¼ÒÆÇÀÎÀÚ 4
platelet factor III
Ç÷¼ÒÆÇÁ¦»ïÀÎÀÚ.
platelet-activating factor (PAF)
Ç÷¼ÒÆÇ Ȱ¼ºÈÀÎÀÚ
platelet-activating factor (paf)
Ç÷¼ÒÆÇȰ¼ºÈÀÎÀÚ(úìá³÷ùüÀàõûùì×í)
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡ Áõ½ÄÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
coronary risk factor
°ü(»ó)(µ¿¸Æ)ÁúȯÀ§Çè¿äÀÎ.
corticotropin-releasing factor =CRF
ºÎ½ÅÇÇÁú ÀÚ±ØÈ£¸£¸ó ¹æÃâÀÎÀÚ(Üù ãìù«òõô§Ð½¡Û¯õóì×í).
cothromboplastin factor VII
ÄÚÆ®·Òº¸ÇÃ¶ó½ºÆ¾.
coupling factor
¹è¿ìÀÎÀÚ.
covering factor
ÇǺ¹ÀÎÀÚ(¡ì×í).
cytotoxic factor
¼¼Æ÷ µ¶¼º ÀÎÀÚ
decay-accelerating factor
ºÐÇØÃËÁøÀÎÀÚ
decay-accelerating factor (DAF)
ºØ±«ÃËÁøÀÎÀÚ
decay-accelerating factor(daf)
Decay-accelerating factor(DAF)
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢À¯¹ßÀÎÀÚ.
differentiation factor
°¨º°¿äÀÎ, °¨º°¿ä¼Ò, °¨º°ÀÎÀÚ
dilution factor
¹±ÈûÀÎÀÚ(ÊÙËöËö), Èñ¼®ÀÎÀÚ.
dilution factor
¹±ÈûÀÎÀÚ(¡ì×í), Èñ¼®ÀÎÀÚ.
dose conversion factor
¼±·®º¯È¯°è¼ö
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½